ADVAC Therapeutics Inc
New Filing
CIK: 0002115406·Pharmaceuticals·DELAWARE·Filed: Mar 10, 2026
Total Offering
$5,000,000
Amount Sold
$500,000
Investors
1
First Sale
Feb 6, 2026
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2022
- Non-Accredited Investors
- Yes
Related Persons
| Name | Role |
|---|---|
| Mark Walter Gossett | Related Person |
Company
SEC Filing
0002115406-26-000003
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free